Eyegate Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.19 |
Market Cap |
$11.37 M |
Shares Outstanding |
45.58 M |
Public Float |
36.14 M |
Address |
271 Waverley Oaks Road Waltham Massachusetts 02452 United States |
Employees | - |
Website | http://www.eyegatepharma.com |
Updated | 07/08/2019 |
EyeGate Pharma is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel (OBG). OBG is a topically-applied eye drop formulation that is being developed under the 510k De Novo path for devices submitted for marketing clearance to the U. |